Tetratherix Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.186x

Tetratherix Ltd cash flow conversion efficiency. Based on the latest financial reports, Tetratherix Ltd (TTX) has a cash flow conversion efficiency ratio of -0.186x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.53 Million ≈ $-3.21 Million USD) by net assets (AU$24.37 Million ≈ $17.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tetratherix Ltd (2023–2025)

Cash flow conversion efficiency of Tetratherix Ltd from 2023 to 2025. This chart illustrates how Tetratherix Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Tetratherix Ltd for real-time trading data and today's change.

Tetratherix Ltd Cash Flow Conversion Ratio Explained

Tetratherix Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tetratherix Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tetratherix Ltd ranked by their cash flow conversion efficiency. Also see market value of Tetratherix Ltd for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Sichuan Dowell Science and Technology Inc
SHE:300535
0.004x
Iberpapel Gestion SA
MC:IBG
0.040x
Kolibri Global Energy Inc. Common stock
NASDAQ:KGEI
0.053x
Motorcar Parts of America Inc
NASDAQ:MPAA
-0.032x
BAJEL PROJECTS LTD
NSE:BAJEL
0.009x
GTM Holdings Corp
TW:1437
-0.002x
Politeknik Metal Sanayi ve
IS:POLTK
0.228x
Fibra Inn
MX:FINN13
-0.011x

Annual Cash Flow Conversion Efficiency for Tetratherix Ltd (2023–2025)

The table below shows the annual cash flow conversion efficiency of Tetratherix Ltd from 2023 to 2025. Review Tetratherix Ltd (TTX) flexibility index to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$27.25 Million
≈ $19.28 Million
AU$-2.67 Million
≈ $-1.89 Million
-0.098x -125.96%
2024-06-30 AU$-6.78 Million
≈ $-4.80 Million
AU$-2.56 Million
≈ $-1.81 Million
0.378x +343.15%
2023-06-30 AU$-4.56 Million
≈ $-3.22 Million
AU$-388.24K
≈ $-274.70K
0.085x --

About Tetratherix Ltd

AU:TTX Australia Biotechnology
Market Cap
$199.36 Million
AU$281.75 Million AUD
Market Cap Rank
#16348 Global
#448 in Australia
Share Price
AU$5.55
Change (1 day)
-0.89%
52-Week Range
AU$3.22 - AU$7.70
All Time High
AU$7.70
About

Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.